Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-27 @ 9:34 PM
Study NCT ID:
NCT01786395
Status:
TERMINATED
Last Update Posted:
2016-01-29
First Post:
2013-01-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Sponsor:
R-Tech Ueno, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2013-01-23
First Submit QC Date:
None
Study First Post Date:
2013-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-27
Last Update Post Date:
2016-01-29
Last Update Post Date Type:
ESTIMATED